Increased incidence of idiopathic inflammatory myopathies after SARS-CoV-2 outbreak: a French interrupted time-series study using the French national health data system and myositis-specific autoantibody data
Increased incidence of idiopathic inflammatory myopathies after SARS-CoV-2 outbreak: a French interrupted time-series study using the French national health data system and myositis-specific autoantibody data. // Journal of Autoimmunity. – URL: https://www.sciencedirect.com/science/article/pii/S0896841126001174?dgcid=rss_sd_all
Increased incidence of idiopathic inflammatory myopathies after SARS-CoV-2 outbreak: a French interrupted time-series study using the French national health data system and myositis-specific autoantibody data. Journal of Autoimmunity. https://www.sciencedirect.com/science/article/pii/S0896841126001174?dgcid=rss_sd_all
“Increased incidence of idiopathic inflammatory myopathies after SARS-CoV-2 outbreak: a French interrupted time-series study using the French national health data system and myositis-specific autoantibody data.” Journal of Autoimmunity.
@article{article552,
title = {Increased incidence of idiopathic inflammatory myopathies after SARS-CoV-2 outbreak: a French interrupted time-series study using the French national health data system and myositis-specific autoantibody data},
journal = {Journal of Autoimmunity},
url = {https://www.sciencedirect.com/science/article/pii/S0896841126001174?dgcid=rss_sd_all}
}
Mesenchymal stem cells (MSCs) have emerged as promising therapeutic agents in regenerative medicine, with their therapeutic effects increasingly attributed to intercellular communication and microenvironmental regulation rather than...
Background Scleral remodeling with myofibroblast activation and extracellular matrix (ECM) degradation drives myopia, but mechanisms remain unclear. This study explored USP33’s role and its regulatory network. Methods We analyzed GEO...
Background Lung cancer is one of the leading causes of cancer-related mortality worldwide. Understanding the molecular mechanisms underlying lung cancer progression is critical for identifying novel therapeutic targets. This study...